Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …

The purpose of our cohort study was to quantify olfactory deficits in Coronavirus disease
2019 (COVID-19) patients using Sniffin'Sticks and a pre-post design to evaluate olfactory …

Introduction: To evaluate the recovery rate of loss of smell (LOS) with objective olfactory
testing in COVID-19 patients. Methods: Adults with confirmed COVID-19 and self-reported …

Background Olfactory dysfunction (OD) has been gaining recognition as a symptom of
COVID-19, but its clinical utility has not been well defined. Objectives To quantify the clinical …

This study prospectively assessed the 6-month prevalence of self-reported and
psychophysically measured olfactory dysfunction in subjects with mild-to-moderate COVID …

Background Considerable evidence suggests that smell dysfunction is common in
coronavirus disease‐2019 (COVID‐19). Unfortunately, extant data on prevalence and …

One of the most striking reported symptoms in CoViD-19 is loss of smell and taste. The
frequency of these impairments and their specificity as a potential central nervous system …

Anosmia constitutes a prominent symptom of COVID-19. However, anosmia is also a
common symptom of acute colds of various origins. In contrast to an acute cold, it appears …

Background Smell and taste disorders occur in COVID-19 with a high prevalence, but little is
known about the duration of the symptoms. In particular, studies using validated olfactory …

While olfactory dysfunction associated with coronavirus disease 2019 (COVID-19) has
attracted considerable interest, few studies have tracked outcomes at serial time points or …